Prostate Cancer Foundation
The Prostate Cancer Foundation (PCF) is a public charity based in Santa Monica, California, that funds prostate cancer research and related patient information and education. Founded in 1993, PCF states that its mission is to end death and suffering from the disease.
Prostate Cancer Foundation at a glance
In short: Prostate Cancer Foundation gave $27.0M across 27 grants in 2024 (avg $999K), top state New York. 15% of 2024 grantees were new. Source: 2024 IRS Form 990.
- Annual giving (2024)
- $26,966,735
- +17.9% vs 2023
- Grants made (2024)
- 27
- -3.6% vs 2023
- Average grant
- $998,768
- +22.2% vs 2023
- Median grant
- $995,843
- Total assets
- $105,767,424
- +15.3% vs 2023
- New grantees (estimate)
- 15% first-time grantees (4 of 27, 2024)
- Primary geography
- New York (25% of itemized 2024 grant dollars)
- Latest 990 filing
- Form 990, 2024 View filing
Data from IRS Form 990, 2024; updated October 2026. New grantees are estimated by matching recipient names across years (methodology).
How to apply to Prostate Cancer Foundation
- Contact
Mailing address: 1250 Fourth Street 360, Santa Monica, CA 90401-1353
Phone: (310) 570-4700
Website: https://pcf.org
Application details from Grantable's research on the foundation's public materials; confirm on its website before applying.
Open Grants
10 open opportunities from Prostate Cancer Foundation
Bayer-PCF Darolutamide Challenge Awards
Prostate Cancer Foundation
Amount
Varies
Deadline
Deadline not published
Bayer-PCF Health Equity Research Awards
Prostate Cancer Foundation
Amount
Varies
Deadline
Deadline not published
Challenge Awards Grant
Prostate Cancer Foundation
Amount
US $300,000 - US $1,500,000
Deadline
Deadline not published
Who Prostate Cancer Foundation funds
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
The largest 2024 recipient was Memorial Sloan Kettering Cancer Center ($4.1M). Together the top 10 received $19.8M.
Grant Size Distribution
161 grants across all recorded years
The most common grant size was in the $500K–1M range: 48 grants of 161 (30%).
Geographic Focus
Where this funder awards grants
PCF says its research awards can support applicants from the global biomedical research community and describes a research footprint spanning 29 countries. In 2024, grant dollars were distributed primarily to recipients in New York (25%), California (22%), Pennsylvania (10%), Texas (10%), and Maryland (10%). PCF also states that it makes awards to foreign institutions and applies the same NIH peer-review standards to foreign research as to domestic research.
Grant Distribution by State
Share of 2024 grant dollars across all 27 itemized grants.
States
Cities
Is Prostate Cancer Foundation open to new grantees?
15%
first-time grantees, 2024
In 2024, 4 of 27 grantees (15%) were first-time recipients. First grants averaged $375K; repeat grants $1.1M. How we count
Medians: $225K first-time, $1M repeat.
Estimate from itemized grant lists in IRS Form 990 filings (2020–2024). Recipient names are matched across years, so a renamed or misspelled grantee can look new; grants to individuals are left out. Methodology.
Giving History
Giving Over Time
Total grant dollars and number of grants per year
From 2020 to 2024, annual grant giving ranged from $18.8M (2020) to $28.0M (2022). In 2024 it made 27 grants totaling $27.0M.
Grants by year
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| Memorial Sloan Kettering Cancer Center New York, NY | Cancer Research | $4,125,355 |
| University of Pennsylvania Philadelphia, PA | Cancer Research | $2,824,975 |
| Johns Hopkins University Baltimore, MD | Cancer Research | $2,585,000 |
| University of Texas MD Anderson Cancer Center Houston, TX | Cancer Research | $2,465,000 |
| University of California San Diego La Jolla, CA | Cancer Research | $2,000,000 |
| University of California San Francisco San Francisco, CA | Cancer Research | $1,274,843 |
| Cedars Sinai Medical Center Los Angeles, CA | Cancer Research | $1,225,000 |
| University of Michigan Ann Arbor, MI | Cancer Research | $1,167,934 |
| Dana-Farber Cancer Institute Boston, MA | Cancer Research | $1,050,000 |
| Weill Cornell Medical College New York, NY | Cancer Research | $1,032,091 |
Ready to take the next step with Prostate Cancer Foundation?
Financial History
Multi-year comparison from IRS filings
PCF reported 27 grants in 2024, 28 in 2023, and 36 in 2022.
| Filing year | Total Assets | Revenue | Expenses | Grants paid | Grants | Net Investment Income |
|---|---|---|---|---|---|---|
| 2024 | $105,767,424 | $56,686,215 | $58,177,919 | $26,966,735 | 27 | $2,658,660 |
| 2023 | $91,770,978 | $57,291,095 | $55,134,763 | $22,876,813 | 28 | $2,398,627 |
| 2022 | $87,285,836 | $71,921,851 | $61,472,068 | $28,018,028 | 36 | $527,048 |
| 2021 | $62,542,873 | $53,016,750 | $41,671,787 | $22,434,297 | 37 | $14,514 |
| 2020 | $43,129,058 | $36,156,917 | $34,952,661 | $18,798,310 | 33 | $321,739 |
Research compiled by Grantable AI from public sources. Last updated October 2026.
Mission & Focus Areas
PCF says it funds research on the biology and treatment of prostate cancer and seeks to accelerate discoveries into therapies and strategies that improve patients’ quality of life and survival. Its stated research priorities include unmet medical needs in the diagnosis and treatment of potentially lethal prostate cancer. The foundation also describes work in public education and a partnership with the Department of Veterans Affairs to expand access to precision-oncology studies for veterans.
PCF’s 2024 filing describes Challenge Awards and TACTICAL Awards as supporting cross-disciplinary teams addressing unmet medical needs. The 2026 Challenge Awards call seeks team science projects on prostate cancer with lethal potential, including basic, translational, clinical, and community-based research. It requires at least three investigators, including a young investigator, and offers up to $1 million per team for two years. Awards cover direct research costs and travel to the Annual PCF Scientific Retreat; clinical trial direct costs are not allowed. For patient studies, applications must include plans for diverse participant representation, along with statistical plans and power calculations.
PCF’s Young Investigator Awards support early-career researchers. The 2026 award call describes three-year awards of $75,000 per year, requires at least one mentor, and does not cover institutional indirect costs. PCF’s program materials identify research areas including diagnostic and therapeutic approaches, PET radiotracers, and precision medicine. Its Bayer-PCF Health Equity Research Awards focus on prostate cancer disparities and outcomes in underrepresented populations, including genetic testing, risk assessment, and patient education. The TACTICAL program description identifies targeted alpha-particle and radioligand therapies, biomarkers, treatment resistance, and advanced imaging as areas of interest.
The 2024 grants went to research and academic institutions. For example, Memorial Sloan Kettering Cancer Center describes its work as cancer prevention, treatment, and cure through patient care, outreach, research, and education. Johns Hopkins University describes a broad research and educational mission across multiple disciplines, including medicine and public health. Cedars-Sinai Medical Center says it combines healthcare with research and education and aims to transform biomedical discoveries for better health.
Grantmaking
In filing year 2024, PCF reported 27 grants totaling $26,966,735. Grant amounts ranged from $6,000 to $4,125,355, with a median of $995,843.
The largest reported awards included $4,125,355 to Memorial Sloan Kettering Cancer Center, $2,824,975 to the University of Pennsylvania, $2,585,000 to Johns Hopkins University, $2,465,000 to the University of Texas MD Anderson Cancer Center, and $2,000,000 to the University of California San Diego. Each was designated for cancer research. Other listed awards included $1,274,843 to the University of California San Francisco and $1,225,000 to Cedars-Sinai Medical Center, also for cancer research.
PCF’s website describes the Young Investigator and TACTICAL Awards as current opportunities. The website also identifies the 2026 PCF TACTICAL Letter of Intent process as closed. The stated September 1, 2026 deadline for the PCUK-PCF Young Investigator Award was in the past as of October 2, 2026.
Leadership & Key People
Leadership team and compensation from IRS filings
The 2024 filing lists Gina Carithers as President and CEO. It also lists Howard Soule as Executive Vice President and Chief Science Officer; Helen Hsieh as Executive Vice President, Finance and Chief Administrative Officer; and Stuart Holden, MD, as Director and Medical Director. Charles Ryan is listed as CEO, with a note that he departed in February 2024.
Prostate Cancer Foundation is led by Charles Ryan, CEO since 2023 (on filings since 2022); 12 of 45 officers listed in 2024 are compensated.
Officers on the 2024 filing
Charles Ryan
CEO
CEO & President → CEO, 2023
On filings since 2022
60 hrs/week
$1.2M (2022) → $961K (2024)
Gina Carithers
President & CEO
Executive Vice President & CCO → Executive Vice President & President, 2023
Executive Vice President & President → President & CEO, 2024
On filings since 2022
50 hrs/week
$377K (2022) → $641K (2024)
Michael Milken
Founder & Chairman
On filings since 2020
15 hrs/week
No compensation reported
Kelvin A. Bagget
Director, Senior Managing Director & Patient Square Capital
Director → Director, Senior Managing Director & Patient Square Capital, 2024
On filings since 2023
2 hrs/week
No compensation reported
Jonathan W. Simons MD
Director
CEO & President → Director, 2022
On filings since 2020
2 hrs/week
$1.3M (2020) → $0 (2024)
Stuart Holden MD
Director & Medical Director
On filings since 2020
30 hrs/week
$225K (2020) → $225K (2024)
The Reverend Rosey Grier
Director
On filings since 2020
10 hrs/week
$42K (2020) → $42K (2024)
Andrea Miyahira
Senior Director & Science
New on the 2024 filing
50 hrs/week
$199K (2024)
Ashley Hunter
Senior Director & Marketing
New on the 2024 filing
50 hrs/week
$186K (2024)
David A. Ederer
Director
On filings since 2020
2 hrs/week
No compensation reported
David Drew Pinsky
Director
On filings since 2020
2 hrs/week
No compensation reported
Emilio Bassini
Director
On filings since 2020
2 hrs/week
No compensation reported
Gregory Brown
Director
On filings since 2020
2 hrs/week
No compensation reported
Henry L. Nordhoff
Director
On filings since 2020
2 hrs/week
No compensation reported
Jason J. Safriet
Director
On filings since 2020
2 hrs/week
No compensation reported
Jeff Zisk
Director
On filings since 2020
2 hrs/week
No compensation reported
Jonathan P. Evans
Director
On filings since 2020
2 hrs/week
No compensation reported
Keith Shoates
Director
On filings since 2020
2 hrs/week
No compensation reported
Kneeland Youngblood MD
Director
On filings since 2020
2 hrs/week
No compensation reported
Lori Milken
Director & Vice President
On filings since 2020
2 hrs/week
No compensation reported
Neal I. Rodin
Director
On filings since 2020
2 hrs/week
No compensation reported
Neil P. Defeo
Director
On filings since 2020
2 hrs/week
No compensation reported
Peter T. Grauer
Director
On filings since 2020
2 hrs/week
No compensation reported
R. Christian B. Evensen
Director
On filings since 2020
2 hrs/week
No compensation reported
Richard V. Sandler
Director
On filings since 2020
2 hrs/week
No compensation reported
Shmuel Meitar
Director
On filings since 2020
2 hrs/week
No compensation reported
Stein Erik Hagen
Director
On filings since 2020
2 hrs/week
No compensation reported
Steven A. Burd
Director
On filings since 2020
2 hrs/week
No compensation reported
The Honorable Earle I. Mack
Director
On filings since 2020
2 hrs/week
No compensation reported
Freda Lewis-Hall MD
Director
On filings since 2021
2 hrs/week
No compensation reported
Michael Muldowney
Director
On filings since 2021
2 hrs/week
No compensation reported
Vincent J. Viola
Director
On filings since 2021
2 hrs/week
No compensation reported
David Taglight
Director
On filings since 2022
2 hrs/week
No compensation reported
Josh Cohen
Director
On filings since 2022
2 hrs/week
No compensation reported
Philip Kantoff MD
Director
On filings since 2022
2 hrs/week
No compensation reported
Howard Shore
Director
On filings since 2023
2 hrs/week
No compensation reported
Helmy Eltoukhy
Director
New on the 2024 filing
2 hrs/week
No compensation reported
Patricia Berns
Director
New on the 2024 filing
2 hrs/week
No compensation reported
George Chong
Controller
On filings since 2020
50 hrs/week
$173K (2020) → $229K (2024)
Helen Hsieh
Executive Vice President, Finance & CAO
Senior Vice President & Finance → Executive Vice President & Finance, 2023
Executive Vice President & Finance → Executive Vice President, Finance & CAO, 2024
On filings since 2020
50 hrs/week
$292K (2020) → $391K (2024)
Howard Soule
Executive Vice President & Chief Science Officer
On filings since 2020
50 hrs/week
$478K (2020) → $581K (2024)
Janet Haber
Vice President & Events
On filings since 2020
50 hrs/week
$217K (2020) → $263K (2024)
Christopher Conway
Vice President & Sports
On filings since 2023
50 hrs/week
$205K (2023) → $243K (2024)
William Oh Left
Executive Vice President & Chief Medical Officer
New on the 2024 filing
50 hrs/week
$186K (2024)
Ralph Finerman
CFO, Treasurer & Secretary
Secretary, Treasurer & Chief Financial Officer → CFO, Treasurer & Secretary, 2021
On filings since 2020
10 hrs/week
No compensation reported
Former officers (19)
- Former: Roxann Taylor (2020–2023) — Director
- Former: Thomas S. Tad Smith Jr. (2020–2023) — Director
- Former: Jonathan Usuka (2021–2023) — Director
- Former: Kari J. Kalstad (2022–2023) — Vice President & Operations
- Former: Jan Haber (2023) — Vice President & Events
- Former: Melanie Ranen (2023) — Vice President & Development
- Former: William Oh (2023) — Executive Vice President & Chief Medical Officer
- Former: Andrew C. Von Eschenbach MD (2020–2022) — Director
- Former: Clark Howard (2020–2022) — Director
- Former: Julie Dibiase (2020–2022) — Vice President & Original Content
- Former: Paul Villanti (2020–2022) — Director
- Former: Shavaun Rigler (2021–2022) — Vice President & Developments
- Former: Kevin P. Pickett (2022) — Executive Vice President & CDO
- Former: Christine Jones (2020–2021) — Chief Operating Officer
- Former: Charles Ryan Joined (2021) — CEO & President
- Former: Andrew Astrachan (2020) — Director
- Former: Ben Engel (2020) — Chief Development Officer
- Former: Christopher Moran (2020) — Director
- Former: James C. Blair (2020) — Director
Data from IRS Form 990 filings, 2020–2024. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2024 IRS filing
The highest reported compensation on the 2024 filing was $961K, to Charles Ryan (CEO (Departed 2/2024)). 12 officers or directors reported compensation on that filing.
Frequently asked questions about Prostate Cancer Foundation
How much does Prostate Cancer Foundation give each year?
Prostate Cancer Foundation gave $27.0M across 27 grants in 2024, according to its 2024 IRS Form 990. In 2023 it gave $22.9M across 28 grants.
What is Prostate Cancer Foundation's typical grant size?
Prostate Cancer Foundation's median grant in 2024 was $995,843, and its average grant was $998,768, across 27 grants on its 2024 IRS Form 990. Organizations receiving their first grant from Prostate Cancer Foundation that year got $375K on average.
Where does Prostate Cancer Foundation give grants?
Prostate Cancer Foundation's top state is New York, with 25% of the grant dollars itemized on its 2024 IRS Form 990. The next largest states were California (22%) and Pennsylvania (10%). The most frequent recipient cities were New York, NY (5 grants), Boston, MA (3 grants), Philadelphia, PA (2 grants) and Los Angeles, CA (2 grants).
Does Prostate Cancer Foundation give general operating support?
Not in 2024: none of the 27 grants with a stated purpose on Prostate Cancer Foundation's 2024 IRS Form 990 were described as general or operating support. Recurring purposes include "Cancer Research" (25 grants).
Who are Prostate Cancer Foundation's largest grantees?
Prostate Cancer Foundation's largest 2024 grantees include Memorial Sloan Kettering Cancer Center ($4,125,355), University of Pennsylvania ($2,824,975) and Johns Hopkins University ($2,585,000), according to its 2024 IRS Form 990. Together they received 35% of its itemized 2024 grant dollars.
How large is Prostate Cancer Foundation?
Prostate Cancer Foundation reported $105.8M in total assets on its 2024 IRS Form 990. Its revenue that year was $56.7M.
What does Prostate Cancer Foundation fund?
PCF says it funds research on the biology and treatment of prostate cancer and seeks to accelerate discoveries into therapies and strategies that improve patients’ quality of life and survival. See mission & focus areas ↑
How do I apply for a grant from Prostate Cancer Foundation?
Prostate Cancer Foundation has no public application process in the sources Grantable reviewed. Check pcf.org for current guidelines, or contact the foundation directly before submitting a request.
What is Prostate Cancer Foundation's EIN?
Prostate Cancer Foundation's EIN (Employer Identification Number) is 95-4418411. IRS Form 990 filing data is available on this page for 2020–2024.
Data last updated October 2026. Sourced from IRS Form 990 filings. Research dossier generated October 2026.
Data update history
(6)
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2020 (received by the IRS September 24, 2021)
- Updated Form 990 for fiscal year 2021 (received by the IRS September 26, 2022)
- Updated Form 990 for fiscal year 2022 (received by the IRS August 24, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS September 15, 2024)
- Updated Form 990 for fiscal year 2024 (received by the IRS September 29, 2025)
- IRS filings on file for fiscal years 2020–2024
Explore Open Grants
Browse active grant opportunities in Prostate Cancer Foundation's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
Conquer Cancer Foundation of the American Society of Clinical Oncology
Alexandria, VA
Conquer Cancer funds cancer research, professional education, and quality-care initiatives, with awards to universities, hospitals, and cancer centers in the U.S. and through international programs. Its 2024 grants ranged from $50,000 to $7.68 million, with a median of $100,000; the profile does not state whether it accepts unsolicited requests.
Assets
$120.7M
Grants
39
Total Given
$17.4M
Alzheimer's Disease & Related Disorders Association Inc
Chicago, IL
The Alzheimer’s Association funds Alzheimer’s and dementia research, including basic, clinical, social and behavioral studies, and supports care, prevention, early detection, awareness, and advocacy. In 2025, its 79 grants ranged from $10,000 to $13.3 million, with a median of $270,750; research opportunities are open to U.S. and international researchers.
Assets
$523.7M
Grants
79
Total Given
$73.3M
Fred Hutchinson Cancer Center
Seatle, WA
Fred Hutchinson Cancer Center funds cancer and infectious disease research, along with Washington community-led projects in cancer prevention, screening, education, and care access. Research grants vary widely (the 2025 median was about $118,000); its community awards were up to $15,000, and Tribal Community Grants up to $50,000 plus indirect costs. Community programs are focused on Washington State; whether unsolicited requests are accepted is not stated.
Assets
$3.6B
Grants
139
Total Given
$88.2M
The Children's Hospital of Philadelphia
Philadelphia, PA
CHOP primarily funds pediatric research at universities, hospitals, and research organizations, and also supports employee-led health projects in communities served by CHOP and its Care Network in Pennsylvania and New Jersey. In 2025, it awarded 138 grants totaling about $50.3 million; the median grant was about $115,000, with awards ranging from about $5,800 to $14 million. The profile does not state whether CHOP accepts unsolicited requests.
Assets
$9.1B
Grants
138
Total Given
$50.3M
Beth Israel Deaconess Medical Center Inc
Charlestown, MA
Beth Israel Deaconess Medical Center funds patient care, medical research, and health care education, with grants also supporting related community needs and infrastructure. Its 2025 grants had a median of about $132,000, though awards ranged widely; 79% of grant dollars went to Massachusetts recipients. The profile does not state whether it accepts unsolicited requests.
Assets
$4.8B
Grants
148
Total Given
$91.2M
Vanderbilt University Medical Center
Nashville, TN
Vanderbilt University Medical Center supports medical and scientific research, health and educational programs, and related institutional purposes, with grants to universities, medical centers, and research organizations. Its 2025 grants had a median of about $116,000, though awards ranged widely; recipients were based across the U.S., with the most funding going to Tennessee. The profile does not state whether it accepts unsolicited requests.
Assets
$7.8B
Grants
246
Total Given
$125.1M
More similar funders
More Funders in California
Cite this profile
Grantable. (2026). Prostate Cancer Foundation funder profile. GrantGraph. Retrieved October 12, 2026, from https://grantable.co/funders/prostate-cancer-foundation-morg_592cb5acc35b4a5599508d46a90b8cfd
BibTeX
@misc{grantable_954418411_2026,
author = {{Grantable}},
title = {{Prostate Cancer Foundation funder profile}},
howpublished = {GrantGraph},
year = {2026},
url = {https://grantable.co/funders/prostate-cancer-foundation-morg_592cb5acc35b4a5599508d46a90b8cfd},
note = {Accessed 2026-10-12. Data licensed CC BY 4.0}
}The figures on this page are open data under CC BY 4.0: reuse them with credit to Grantable and a link. Download the data.
Figures come from Prostate Cancer Foundation's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
Prostate Cancer Foundation down — hundreds of funders to go?